Shannon Conley to Retinal Diseases
This is a "connection" page, showing publications Shannon Conley has written about Retinal Diseases.
Connection Strength
1.742
-
Delineating the Clinical Phenotype of Patients With the c.629C>G, p.Pro210Arg Mutation in Peripherin-2. Invest Ophthalmol Vis Sci. 2022 07 08; 63(8):19.
Score: 0.745
-
Nanoparticles for retinal gene therapy. Prog Retin Eye Res. 2010 Sep; 29(5):376-97.
Score: 0.321
-
Prph2 disease mutations lead to structural and functional defects in the RPE. FASEB J. 2022 05; 36(5):e22284.
Score: 0.184
-
PRPH2/RDS and ROM-1: Historical context, current views and future considerations. Prog Retin Eye Res. 2016 05; 52:47-63.
Score: 0.119
-
A review of therapeutic prospects of non-viral gene therapy in the retinal pigment epithelium. Biomaterials. 2013 Sep; 34(29):7158-67.
Score: 0.100
-
Overexpression of ROM-1 in the cone-dominant retina. Adv Exp Med Biol. 2012; 723:633-9.
Score: 0.090
-
AAV and compacted DNA nanoparticles for the treatment of retinal disorders: challenges and future prospects. Invest Ophthalmol Vis Sci. 2011 May 10; 52(6):3051-9.
Score: 0.086
-
Focus on molecules: RDS. Exp Eye Res. 2009 Sep; 89(3):278-9.
Score: 0.074
-
Expression and role of p53 in the retina. Invest Ophthalmol Vis Sci. 2012 Mar 15; 53(3):1362-71.
Score: 0.023